TickerFacts.

Akari Therapeutics Plc (AKTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

67.33B
Year ended 2025-12-31
2012-12-31: 12.46M2013-12-31: 21.08M2014-12-31: 85.52M2015-12-31: 852.09M2016-12-31: 1.18B2017-12-31: 1.25B2018-12-31: 1.54B2019-12-31: 1.83B2020-12-31: 3.16B2021-12-31: 4.29B2022-12-31: 6.24B2023-12-31: 9.79B2024-12-31: 23.89B2025-12-31: 67.33B67.33B
2012-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3167.33B+181.8%2026-03-30, From 2025-01-01
2024-12-3123.89B+144.0%2026-03-30, From 2024-01-01
2023-12-319.79Bn/c2025-04-15, From 2023-01-01
2022-12-316.24Bn/c2024-03-29, From 2022-01-01
2021-12-314.29B+35.9%2023-05-01, From 2021-01-01
2020-12-313.16B+72.5%2023-05-01, From 2020-01-01
2019-12-311.83B+18.9%2022-05-16, From 2019-01-01
2018-12-311.54B+23.5%2021-04-21, From 2018-01-01
2017-12-311.25B+5.9%2020-03-31, From 2017-01-01
2016-12-311.18B+38.2%2019-04-23, From 2016-01-01
2015-12-31852.09Mn/c2018-07-18, From 2015-01-01
2014-12-3185.52Mn/c2017-03-31, From 2014-01-01
2013-12-3121.08M+69.2%2015-02-11, From 2013-01-01
2012-12-3112.46Mn/a2015-02-11, From 2012-01-01